Brought to you by 
Jnana closes $50mm Series A round
18 Dec 2017
Executive Summary
Jnana Therapeutics Inc. has launched with $50mm in Series A funding from seed backers Polaris Partners and Avalon Ventures and new investors Versant Ventures, AbbVie Ventures, and Pfizer R&D Innovate.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Jnana closes $50mm Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice